Louise Rodino-Klapac - Mar 7, 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Head of R&D, CSO
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Louise Rodino-Klapac
Stock symbol
SRPT
Transactions as of
Mar 7, 2024
Transactions value $
-$173,625
Form type
4
Date filed
3/11/2024, 08:00 PM
Previous filing
Mar 6, 2024
Next filing
Jun 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -$61.7K -512 -0.74% $120.49 69K Mar 7, 2024 Direct F1
transaction SRPT Common Stock Tax liability -$112K -909 -1.32% $123.14 68.1K Mar 8, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.
F2 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.